Literature DB >> 8648331

SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele.

M Lehtovirta1, H Soininen, M P Laakso, K Partanen, S Helisalmi, A Mannermaa, M Ryynänen, J Kuikka, P Hartikainen, P J Riekkinen.   

Abstract

OBJECTIVES: The epsilon 4 allele of apolipoprotein E (ApoE) is a risk factor for late onset Alzheimer's disease. ApoE is present in senile plaques, neurofibrillary tangles, and cerebrovascular amyloid, and it is implicated in synaptogenesis. The effect of ApoE polymorphism on the volumes of hippocampus, amygdala, and frontal lobe was studied. The hypothesis was that the patients with Alzheimer's disease carrying the epsilon 4 allele have more pronounced atrophy. The relation of ApoE and cerebral blood flow on cortical areas was also assessed.
METHODS: Fifty eight patients with Alzheimer's disease at the early stage of the disease and 34 control subjects were studied. Patients with Alzheimer's disease were divided into subgroups according to the number of the epsilon 4 alleles. Volumes were measured by MRI and regional cerebral blood flow ratios referred to the cerebellum were examined by 99mTc-HMPAO SPECT. ApoE genotypes were determined by digestion of ApoE polymerase chain reaction products with the restriction enzyme Hha1.
RESULTS: patients with Alzheimer's disease had smaller volumes of hippocampi and amygdala compared with control subjects, and the patients with Alzheimer's disease homozygous for the epsilon 4 allele had the most prominent volume loss in the medial temporal lobe structures. The frontal lobe volumes did not differ significantly. All patients with Alzheimer's disease had bilateral temporoparietal hypoperfusion and the subgroups with one or no epsilon 4 alleles also had frontal hypoperfusion compared with control subjects. The occipital perfusion ratios tended to decrease with increasing number of epsilon 4 alleles.
CONCLUSIONS: Patients with Alzheimer's disease homozygous for the epsilon 4 allele seem to have severe damage in the medial temporal lobe structures early in the disease process and differ from the patients with Alzheimer's disease with one or no epsilon 4 alleles.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648331      PMCID: PMC1073948          DOI: 10.1136/jnnp.60.6.644

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  44 in total

1.  The investigation of Alzheimer's disease with single photon emission tomography.

Authors:  A Burns; M P Philpot; D C Costa; P J Ell; R Levy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

2.  Biochemical measurements in Alzheimer's disease reveal a necessity for improved neuroimaging techniques to study metabolism.

Authors:  A Najlerahim; D M Bowen
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

3.  Critical analysis of the disability in Parkinson's disease.

Authors:  D D Webster
Journal:  Mod Treat       Date:  1968-03

4.  Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease.

Authors:  D Perani; V Di Piero; G Vallar; S Cappa; C Messa; G Bottini; A Berti; D Passafiume; G Scarlato; P Gerundini
Journal:  J Nucl Med       Date:  1988-09       Impact factor: 10.057

5.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

Review 6.  Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype.

Authors:  W J Strittmatter; K H Weisgraber; M Goedert; A M Saunders; D Huang; E H Corder; L M Dong; R Jakes; M J Alberts; J R Gilbert
Journal:  Exp Neurol       Date:  1994-02       Impact factor: 5.330

7.  Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123.

Authors:  K A Johnson; S T Mueller; T M Walshe; R J English; B L Holman
Journal:  Arch Neurol       Date:  1987-02

8.  Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease.

Authors:  J P Seab; W J Jagust; S T Wong; M S Roos; B R Reed; T F Budinger
Journal:  Magn Reson Med       Date:  1988-10       Impact factor: 4.668

9.  Pathological verification of ischemic score in differentiation of dementias.

Authors:  W G Rosen; R D Terry; P A Fuld; R Katzman; A Peck
Journal:  Ann Neurol       Date:  1980-05       Impact factor: 10.422

10.  Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

Authors:  B T Hyman; G W Van Hoesen; A R Damasio; C L Barnes
Journal:  Science       Date:  1984-09-14       Impact factor: 47.728

View more
  31 in total

Review 1.  A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: a neuroimaging profile.

Authors:  Konstantine K Zakzanis; Simon J Graham; Zachariah Campbell
Journal:  Neuropsychol Rev       Date:  2003-03       Impact factor: 7.444

2.  Age effects on atrophy rates of entorhinal cortex and hippocampus.

Authors:  An-Tao Du; Norbert Schuff; Linda L Chao; John Kornak; William J Jagust; Joel H Kramer; Bruce R Reed; Bruce L Miller; David Norman; Helena C Chui; Michael W Weiner
Journal:  Neurobiol Aging       Date:  2005-06-14       Impact factor: 4.673

3.  ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain.

Authors:  Veera Venkata Ratnam Bandaru; Juan Troncoso; David Wheeler; Olga Pletnikova; Jessica Wang; Kathy Conant; Norman J Haughey
Journal:  Neurobiol Aging       Date:  2007-09-20       Impact factor: 4.673

4.  Cardiac index is associated with brain aging: the Framingham Heart Study.

Authors:  Angela L Jefferson; Jayandra J Himali; Alexa S Beiser; Rhoda Au; Joseph M Massaro; Sudha Seshadri; Philimon Gona; Carol J Salton; Charles DeCarli; Christopher J O'Donnell; Emelia J Benjamin; Philip A Wolf; Warren J Manning
Journal:  Circulation       Date:  2010-08-02       Impact factor: 29.690

Review 5.  Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.

Authors:  Y Y Hsu; A T Du; N Schuff; M W Weiner
Journal:  J Geriatr Psychiatry Neurol       Date:  2001       Impact factor: 2.680

6.  Olfactory deficit detected by fMRI in early Alzheimer's disease.

Authors:  Jianli Wang; Paul J Eslinger; Richard L Doty; Erin K Zimmerman; Robert Grunfeld; Xiaoyu Sun; Mark D Meadowcroft; James R Connor; Joseph L Price; Michael B Smith; Qing X Yang
Journal:  Brain Res       Date:  2010-08-13       Impact factor: 3.252

7.  Dementia, quantitative neuroimaging, and apolipoprotein E genotype.

Authors:  E D Bigler; C M Lowry; C V Anderson; S C Johnson; J Terry; M Steed
Journal:  AJNR Am J Neuroradiol       Date:  2000 Nov-Dec       Impact factor: 3.825

8.  Apolipoprotein E isoform-dependent effects on anxiety and cognition in female TR mice.

Authors:  Jessica A Siegel; Gwendolen E Haley; Jacob Raber
Journal:  Neurobiol Aging       Date:  2010-04-18       Impact factor: 4.673

Review 9.  The role of APOE in cerebrovascular dysfunction.

Authors:  Leon M Tai; Riya Thomas; Felecia M Marottoli; Kevin P Koster; Takahisa Kanekiyo; Alan W J Morris; Guojun Bu
Journal:  Acta Neuropathol       Date:  2016-02-16       Impact factor: 17.088

10.  Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study.

Authors:  Robyn A Honea; Eric Vidoni; Amith Harsha; Jeffrey M Burns
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.